An international clinical trial aimed at preventing Alzheimer’s disease (AD) in young adults who are at risk of developing ...

The U.S. Food and Drug Administration (FDA) has approved monthly maintenance dosing for Leqembi (lecanemab), a treatment for early Alzheimer’s disease.

With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help ...